InsidersTradesSigma
Follow the EUROAPI share price and the full insider trade history of the company, a publicly traded company based in France. Shares are listed on the FR market, under the authority of AMF. Operating in the Healthcare & Pharma sector, EUROAPI has recorded 25 reports. Market capitalisation: €93.6m. The latest transaction was filed on 31 May 2023 (Acquisition). Among the most active insiders: Karl ROTTHIER. Every trade is free.
25
Insider Decl.
n/a
Thresholds
€497,209
24 ops.
Buy Volume
n/a
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate EUROAPI Underperform (bearish), based on 4 analysts. Average price target: €1.40.
65Σ signal
Fundamental score
Ranked 19,894 of 29,064 companies
39.5
score / 100
Value66
Quality13
FCF yld53%
Earn yld·
EV/EBITDA15.9x
ROE-24%
Gross mgn17%
Net mgn-25%
Debt/EBITDA6.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 31 May 2023
Declarations25 total
610 shares@ €14.774414.3% of flowActionEuronext ParisISIN FR0014008VX52022DD846769
Canonical exit: 4 Sept 2022 (T+90)
11,283,226 shares@ €13.2941100.0% of flowActionHors plateforme de négociationISIN FR0014008VX52023DD900733
Canonical exit: 15 Sept 2022 (T+90)
630 shares@ €14.328214.3% of flowActionEuronext ParisISIN FR0014008VX52022DD849191
Canonical exit: 22 Sept 2022 (T+90)
416 shares@ €14.4020.0% of flowActionEuronext ParisISIN FR0014008VX52022DD848579
Canonical exit: 18 Sept 2022 (T+90)
615 shares@ €14.69614.3% of flowActionEuronext ParisISIN FR0014008VX52022DD848587
Canonical exit: 19 Sept 2022 (T+90)
11,283,226 shares@ €13.2941100.0% of flowActionEuronext ParisISIN FR0014008VX52022DD848283
646 shares@ €13.96814.3% of flowActionEuronext ParisISIN FR0014008VX52022DD847910
Canonical exit: 12 Sept 2022 (T+90)
642 shares@ €14.042314.3% of flowActionEuronext ParisISIN FR0014008VX52022DD847913
Canonical exit: 14 Sept 2022 (T+90)
425 shares@ €14.12220.0% of flowActionEuronext ParisISIN FR0014008VX52022DD847760
Canonical exit: 14 Sept 2022 (T+90)
424 shares@ €14.1520.0% of flowActionEuronext ParisISIN FR0014008VX52022DD847646
Canonical exit: 13 Sept 2022 (T+90)
8,000 shares@ €13.8642.6% of flowActionEuronext ParisISIN FR0014008VX52022DD847418
Canonical exit: 12 Sept 2022 (T+90)
428 shares@ €13.98220.0% of flowActionEuronext ParisISIN FR0014008VX52022DD845571
Canonical exit: 31 Aug 2022 (T+90)
1,322 shares@ €13.603612.5% of flowActionEuronext ParisISIN FR0014008VX52022DD845566
Canonical exit: 31 Aug 2022 (T+90)
440 shares@ €13.58620.0% of flowActionEuronext ParisISIN FR0014008VX52022DD845570
Canonical exit: 29 Aug 2022 (T+90)
625 shares@ €14.433814.3% of flowActionEuronext ParisISIN FR0014008VX52022DD845193
Canonical exit: 1 Sept 2022 (T+90)
660 shares@ €13.639614.3% of flowActionEuronext ParisISIN FR0014008VX52022DD845192
Canonical exit: 29 Aug 2022 (T+90)
1,313 shares@ €13.701312.5% of flowActionEuronext ParisISIN FR0014008VX52022DD844864
Canonical exit: 30 Aug 2022 (T+90)
1,366 shares@ €13.159412.5% of flowActionEuronext ParisISIN FR0014008VX52022DD844861
Canonical exit: 23 Aug 2022 (T+90)
1,349 shares@ €13.331412.5% of flowActionEuronext ParisISIN FR0014008VX52022DD844862
Canonical exit: 30 Aug 2022 (T+90)
3,750 shares@ €13.4119.3% of flowActionEuronext ParisISIN FR0014008VX52022DD844642
Canonical exit: 28 Aug 2022 (T+90)
1,352 shares@ €13.297912.5% of flowActionEuronext ParisISIN FR0014008VX52022DD843515
Canonical exit: 17 Aug 2022 (T+90)
7,500 shares@ €13.2138.1% of flowActionEuronext ParisISIN FR0014008VX52022DD843108
Canonical exit: 21 Aug 2022 (T+90)
1,388 shares@ €12.958512.5% of flowActionEuronext ParisISIN FR0014008VX52022DD842669
Canonical exit: 15 Aug 2022 (T+90)
1,277 shares@ €14.079612.5% of flowActionEuronext ParisISIN FR0014008VX52022DD841985
Canonical exit: 11 Aug 2022 (T+90)
1,428 shares@ €12.601412.5% of flowActionEuronext ParisISIN FR0014008VX52022DD841476
Canonical exit: 8 Aug 2022 (T+90)
25 of 25 declarations
关于 EUROAPI
EUROAPI 是欧洲领先的活性药物成分 (API) 和中间体生产商，这些成分用于制造人类和兽医药物。公司通过两个互补的商业引擎开发、制造、营销和分销 API：API 解决方案（涵盖广泛的标准和专业分子产品组合）和 CDMO（合同开发和制造组织）活动（EUROAPI 通过此支持制药和生物技术客户开发和生产更复杂的分子）。该集团表示，它管理着大约 200 种 API 的产品组合，其工业足迹完全位于欧洲。 EUROAPI 的近期历史与赛诺菲 (Sanofi) 密切相关。该公司是从赛诺菲内部原有的 API 和中间体业务剥离出来的，并于 2022 年 5 月 6 日在泛欧交易所巴黎上市，股票代码为 EAPI，ISIN 为 FR0014008VX5。上市时，赛诺菲仍是其长期战略合作伙伴，而 EUROAPI 则获得了更大的运营和商业独立性。 从竞争角度来看，EUROAPI 依靠三个关键优势：广泛的产品基础、多样化的制造技术以及服务高度复杂分子的能力。该公司强调在发酵、复杂化学合成、肽、寡核苷酸、前列腺素、皮质类固醇、激素、抗感染药物、阿片类药物和其他高价值分子方面的专业知识。在其最新的公开通讯中，EUROAPI 表示按销售额计算，它是小分子 API 领域的全球第一，并报告 2024 年销售额为 911.9 million 欧元。 在运营方面，EUROAPI 依赖于一个欧洲制造网络，该网络包括五到六个生产基地（具体取决于公司和市场材料中对足迹的描述方式），设施位于法国、英国、德国、意大利和匈牙利。这一足迹使该集团能够为 80 多个国家的客户提供服务，并服务于全球的制药公司、生物技术公司和仿制药制造商。该集团还维持着一个国际研发组织，旨在加速创新、开发新工艺并加强其 CDMO 产品。 EUROAPI 的显著特点包括其在技术要求高的 API 市场中的地位、其深厚的欧洲工业基础以及日益专注于最有利可图的产品和合同的战略。公司 2024 年的通用注册文件强调了产品组合的合理化和盈利能力的提高，而 2026 年的展望仍指出商业环境充满挑战。
